drugset / Trial / NCT04962906
Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes
RandomizedParallel-groupSingle-blindHealth-services research
Summary
To determine whether a heterologous vaccination regimen in individuals with no known previous history of COVID-19 is non-inferior to that observed with counterpart regimens currently in use in Argentina.
Timeline
- Start
- 2021-07-05
- Primary completion
- 2021-08-05
- Completion
- 2021-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | AZD1222 | Vaccine | — | — |
| Comparator | BBIBP-CorV | Vaccine | — | — |
| Comparator | Gam-COVID-Vac | Vaccine | — | — |
Indications
No indication recorded.